Emeline Van Craenenbroeck
Overview
Explore the profile of Emeline Van Craenenbroeck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moholdt T, Aye C, Bahls M, Crispi F, Ghossein-Doha C, Goossens E, et al.
Eur J Prev Cardiol
. 2025 Feb;
PMID: 39993159
Adverse pregnancy outcomes, such as gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction, and prematurity, can increase the risk of future cardiovascular disease (CVD) in the offspring. This document...
2.
Mueller S, Kabelac M, Fegers-Wustrow I, Winzer E, Gevaert A, Beckers P, et al.
Eur J Prev Cardiol
. 2024 Oct;
PMID: 39453789
Aims: Exercise training (ET) is an effective therapy in heart failure with preserved ejection fraction (HFpEF), but the influence of different ET characteristics is unclear. We aimed to evaluate the...
3.
Devoldere J, Droogmans S, Heggermont W, Van Craenenbroeck E
Acta Cardiol
. 2024 Sep;
79(8):897-908.
PMID: 39254605
Background: The 2021 European Society of Cardiology (ESC) guidelines recommended a shift from a traditional hierarchical treatment for heart failure with reduced ejection fraction (HFrEF) to a four-pillar medical therapy...
4.
Vorlat A, van Eijk J, Wiersma S, Smid L, Depooter S, Paelinck B, et al.
Int J Cardiol Heart Vasc
. 2024 Sep;
54:101479.
PMID: 39221115
Background: Cardiac fibrosis is increasingly recognized as a marker of worse outcomes in long-term follow-up after heart transplantation (HTX). We investigated the clinical determinants and biomarkers of focal and interstitial...
5.
Sliwa K, Rakisheva A, Viljoen C, Pfeffer T, Simpson M, Jackson A, et al.
Eur J Heart Fail
. 2024 Aug;
26(10):2143-2154.
PMID: 39115028
This statement focuses on the fact that women with peripartum cardiomyopathy (PPCM) have a substantial mortality and morbidity rate. Less than 50% of patients have full recovery of their cardiac...
6.
Kouidi E, Hanssen H, Anding-Rost K, Cupisti A, Deligiannis A, Grupp C, et al.
Eur J Prev Cardiol
. 2024 Apr;
31(12):1493-1515.
PMID: 38593202
Cardiovascular (CV) morbidity and mortality is high in patients with chronic kidney disease (CKD). Most patients reveal a high prevalence of CV risk factors such as diabetes or arterial hypertension...
7.
Vanreusel I, Hens W, Van Craenenbroeck E, Van Berendoncks A, Segers V
Curr Cardiol Rev
. 2024 Feb;
20(4):e210224227260.
PMID: 38409710
Although there is a continually growing number of patients with congenital heart disease (CHD) due to medical and surgical advances, these patients still have a poorer prognosis compared to healthy...
8.
Vanreusel I, Taeymans J, Van Craenenbroeck E, Segers V, Van Berendoncks A, Briede J, et al.
Free Radic Res
. 2023 Nov;
57(6-12):470-486.
PMID: 38000042
Oxidative stress is an important pathophysiological mechanism in the development of numerous cardiovascular disorders. To improve therapy and preventive strategies, clinicians need a better understanding of the underlying pathophysiological mechanisms...
9.
Perik M, Govaerts E, Laga S, Goovaerts I, Saenen J, Van Craenenbroeck E, et al.
Front Genet
. 2023 Sep;
14:1251675.
PMID: 37719708
variants cause Loeys-Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly...
10.
Bonaros N, Van Craenenbroeck E
Eur J Cardiothorac Surg
. 2023 May;
64(4).
PMID: 37233205
No abstract available.